logo
    • English
      • 简体中文
      • 繁體中文
  • Home
  • Articles
    • Insights
    • Client Press Releases
    • Client Coverage
  • Interviews
    • CEO Interview
    • PDAC Interview
  • Clients
    • Featured Companies
    • In-depth Analysis
  • Markets
    • Stock Tracker
    • Markets at a glance
    • Investing 101
      • Investing in Mining 101
        • Gold and Precious Metals
        • Electric and Battery Metals
        • Base Metals
        • Other Mining Subsectors
  • METALS 100
  • GCFF Event
    • Next Event
    • Past Events
  • Home
  • Pharmaceutical
Filter

Pharmaceutical

Categories

Sectors

Locations

Exchange

中美药企冠科美博APL-102一期临床试验获批

Apollomics, Inc. Receives China Investigational New Drug Approval for APL-102 to Initiate a Phase 1 Study

Nov 13, 2020

Life Science

医疗保健精选——阿斯利康与CCT合作进行新冠疫苗试验; CureVac候选新冠疫苗在低温下稳定

Healthcare Roundup – AstraZeneca teams up with CCT to conduct COVID-19 vaccine trials in Arizona; CureVac COVID-19 vaccine candidate stable at cool temp

Nov 13, 2020

Life Science

医疗保健精选——Sorrento申请新冠抗体鼻喷雾剂的新药试验;欧盟与辉瑞和BioNTech接近达成新冠疫苗供应协议

Healthcare Roundup – Sorrento files IND for antibody nasal spray for COVID-19; EU next to reach deal for Pfizer, BioNTech vaccine

Nov 12, 2020

Life Science

CEPI资助中国三叶草生物开发“S-三聚体”新冠候选疫苗

CEPI Extends Partnership With Clover Biopharmaceuticals to Fund COVID-19 Vaccine Candidate Through Global Phase 2/3 Study to Licensure

Nov 3, 2020

Life Science

医疗保健精选——FDA对COVID-19疫苗紧急使用授权缺乏热情,阿斯利康新冠疫苗协议的毛利润高达20%

Healthcare Roundup – FDA getting cold feet on EUA nod for COVID-19 vaccines, AstraZeneca COVID-19 deal allows 20% gross profit

Oct 23, 2020

Life Science

医疗保健精选——FDA批准吉利德瑞德西韦,Moderna完成新冠疫苗患者的三期研究入组

Healthcare Roundup – FDA OKs Gilead’s remdesivir, Moderna completes enrollment for Phase 3 study of Covid-19 vaccine

Oct 23, 2020

Life Science

医疗保健精选——CVS希望再招募15,000名员工,辉瑞和Moderna新冠疫苗的关键研究接近入组目标

Healthcare Roundup – CVS looks to hire another 15,000 employees, Pfizer and Moderna pivotal studies on COVID-19 vaccines near enrollment targets

Oct 20, 2020

Life Science

中国科兴获投资,加速COVID-19疫苗开发

Healthcare Roundup – Sinovac’s COVID-19 vaccine offered by Chinese city for emergency use, CytoDyn to discuss DSMC’s review of interim analysis in COVID-19

Oct 17, 2020

Life Science

医疗保健精选——瑞德昔韦对新冠病毒死亡率几乎没有影响,世界卫生组织将吉利德的瑞德昔韦加入资格预审清单

Healthcare Roundup – Remdesivir has little effect on mortality, Gilead Science lands WHO distinction for remdesivir

Oct 16, 2020

Life Science

医疗保健精选——美国确认首例新冠二次感染病例,Relief/NeuroRx报告令人鼓舞的Aviptadil数据

Healthcare Roundup – First case of COVID-19 reinfection confirmed in the U.S.; Relief/NeuroRx reports encouraging Aviptadil data

Oct 13, 2020

Life Science

医疗保健综述-礼来/信达生物利妥昔单抗注射液在中国获得许可;辉瑞和BioNTech提交COVID-19候选疫苗滚动审查申请

Healthcare Roundup – Lilly/Innovent rituximab injection OK’d in China; BioNTech, Pfizer announce rolling submission for COVID-19 vaccine candidate

Oct 9, 2020

Life Science

Healthcare Roundup – Regeneron +2.3% after Trump praises drug, Aprea on go with early-stage study with APR-548

Oct 8, 2020

Life Science

医疗保健精选——Argenx建立新的合作伙伴关系,Imbio与Genentech合作

Healthcare Roundup – Argenx inks new partnerships, Imbio teams up with Genentech

Oct 7, 2020

Life Science

医疗保健精选——Crispr Therapeutics获买入评级,再鼎医药开始进行retifanlimab的后期研究

Healthcare Roundup – Crispr Therapeutics started with Buy at BofA, Zai Lab commences late-stage study of retifanlimab

Oct 6, 2020

Life Science

Healthcare Roundup – Trump taking Regeneron antibody cocktail, Study of AstraZeneca COVID-19 vaccine resumes in Japan

Oct 2, 2020

Life Science

医疗保健精选——亚马逊近20,000名工人感染新冠病毒,FDA向贝克曼试剂授权紧急使用授权

Healthcare Roundup – Amazon says nearly 20,000 workers got COVID-19, FDA OKs emergency use of Beckman test

Oct 2, 2020

Life Science

医疗保健精选——Moderna不会在11月25日之前申请紧急使用授权,阿斯利康/牛津COVID-19疫苗在欧洲加速审查

Healthcare Roundup – Moderna won’t seek FDA emergency use nod before November 25, AstraZeneca/Oxford COVID-19 vaccine nabs accelerated review in Europe

Oct 1, 2020

Life Science

医疗保健精选——Aptorum Group公开募集900万美元资金,辉瑞与中国基石药业达成交易

Healthcare Roundup – Aptorum Group raises $9M in public offering, Pfizer inks deal with CStone

Sep 30, 2020

Life Science

  • ‹‹ Previous
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • Next ››

We connect Investors to Opportunities.

Financial Market Data copyright © 2020 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

 
QuoteMedia logo

Head Office

  • 2209 – 1111 Alberni Street
    Vancouver, BC Canada V6E 4V2
  • Phone: (604) 488-8878
  • Fax: (604) 488-0868
  • Toll Free: 1 (866) 833-5517
  • Email: [email protected]

Shanghai Office

  • 06 - 607, 6/f. No.800 Shangcheng
    Road Pudong New District Shanghai,
    China
  • Phone: 021-68883919
  • Fax: 021-68882879
  • Email: [email protected]

Important Links

  • Privacy Policy
  • Terms of Use
  • Content Partner
  • NAI500 Investor Relations Services
  • About Us
  • Contact Us

© 2026 NAI Interactive Ltd. All Rights Reserved

gcff

logo

Website Design Vancouver by Nirvana Canada